Perrigo | PRGO - Gross Profit On Sales


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Perrigo

Perrigo reported $413.8M in Gross Profit on Sales for its fiscal quarter ending in March of 2023.


Gross Profit On Sales Change
Abbott ABT:US USD 5.42B 135M
Bayer BAYN:GR EUR 8.66B 1.42B
Bristol-Myers Squibb BMY:US USD 8.77B 114M
Catalent CTLT:US USD 387M 129M
Dr.Reddys Laboratories DRRD:IN INR 36B 11.89B
Eli Lilly LLY:US USD 5.33B 420.4M
Endo International ENDP:US USD 347.82M 10.83M
Horizon Pharma HZNP:US USD 623.5M 77.75M
J&J JNJ:US USD 16.35B 356M
Merck & Co MRK:US USD 11.14B 1.15B
Nestle NESN:VX CHF 21.73B 785M
Pacira PCRX:US USD 111.32M 1.28M
Perrigo PRGO:US USD 413.8M 31.2M
Pfizer PFE:US USD 13.26B 1.21B
Phibro Animal Health PAHC:US USD 75.54M 1.84M
Reckitt Benckiser Group PLC RB/:LN GBP 4.36B 355M
Supernus Pharmaceuticals SUPN:US USD 130.3M 14.07M
Teva Pharmaceutical Industries Ltd TEVA:IT USD 1.65B 454M
Zoetis ZTS:US USD 1.45B 57M